Literature DB >> 31251583

Aryl Sulfate is a Useful Motif for Conjugating and Releasing Phenolic Molecules: Sulfur Fluorine Exchange Click Chemistry Enables Discovery of Ortho-Hydroxy-Protected Aryl Sulfate Linker.

Suho Park, Sun Young Kim, Jongun Cho, Doohwan Jung, Donghoon Seo, Jaeho Lee, Sangkwang Lee, Sanghyeon Yun, Hyangsook Lee, Okku Park, Beomseok Seo, Sung Ho Woo, Tae Kyo Park.   

Abstract

A new self-immolative linker motif, Ortho Hydroxy-Protected Aryl Sulfate (OHPAS), was devised, and OHPAS-containing antibody drug conjugates (ADC) were tested in vitro and in vivo. Conveniently synthesized using Sulfur Fluorine Exchange (SuFEx) chemistry, it is based structurally on diaryl sulfate, with one aryl acting as a payload and the other as a self-immolative sulfate unit having a latent phenol function at the ortho position. The chemically stable OHPAS linker was stable in plasma samples from 5 different species, yet it can release the payload molecule smoothly upon chemical or biological triggering. The payload release proceeds via intramolecular cyclization, producing a cyclic sulfate coproduct that eventually hydrolyzes to a catechol monosulfate. A set of OHPAS-containing ADCs based on Trastuzumab were prepared with a drug to antibody ratio of ∼2, and were shown to be cytotoxic in 5 different cancer cell lines in vitro and dose-dependently inhibited tumor growth in a NCI-N87 mouse xenograft model. We conclude that OHPAS conjugates will be of considerable use for delivering phenol-containing payloads to tissues targeted for medical intervention.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31251583     DOI: 10.1021/acs.bioconjchem.9b00340

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  8 in total

1.  Copper-Free Click Enabled Triazabutadiene for Bioorthogonal Protein Functionalization.

Authors:  Anjalee N Wijetunge; Garrett J Davis; Mehrdad Shadmehr; Julia A Townsend; Michael T Marty; John C Jewett
Journal:  Bioconjug Chem       Date:  2021-01-25       Impact factor: 4.774

Review 2.  Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment.

Authors:  Gengqi Liu; Jonathan F Lovell; Lei Zhang; Yumiao Zhang
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

3.  Assessments of the In Vitro and In Vivo Linker Stability and Catabolic Fate for the Ortho Hydroxy-Protected Aryl Sulfate Linker by Immuno-Affinity Capture Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometric Assay.

Authors:  Byeong Ill Lee; Seo-Jin Park; Yuri Park; Seok-Ho Shin; Jang-Mi Choi; Min-Jae Park; Jeong-Hyeon Lim; Sun Young Kim; Hyangsook Lee; Young G Shin
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

4.  Synthesis and preliminary evaluation of octreotate conjugates of bioactive synthetic amatoxins for targeting somatostatin receptor (sstr2) expressing cells.

Authors:  Alla Pryyma; Kaveh Matinkhoo; Yong Jia Bu; Helen Merkens; Zhengxing Zhang; Francois Bénard; David M Perrin
Journal:  RSC Chem Biol       Date:  2021-10-07

Review 5.  Antibody-drug conjugates: Recent advances in linker chemistry.

Authors:  Zheng Su; Dian Xiao; Fei Xie; Lianqi Liu; Yanming Wang; Shiyong Fan; Xinbo Zhou; Song Li
Journal:  Acta Pharm Sin B       Date:  2021-04-06       Impact factor: 11.413

6.  Meeting key synthetic challenges in amanitin synthesis with a new cytotoxic analog: 5'-hydroxy-6'-deoxy-amanitin.

Authors:  Alla Pryyma; Kaveh Matinkhoo; Antonio A W L Wong; David M Perrin
Journal:  Chem Sci       Date:  2020-10-15       Impact factor: 9.825

Review 7.  The Chemistry Behind ADCs.

Authors:  Vesela Kostova; Patrice Désos; Jérôme-Benoît Starck; Andras Kotschy
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-07

8.  Silicon-Free SuFEx Reactions of Sulfonimidoyl Fluorides: Scope, Enantioselectivity, and Mechanism.

Authors:  Dong-Dong Liang; Dieuwertje E Streefkerk; Daan Jordaan; Jorden Wagemakers; Jacob Baggerman; Han Zuilhof
Journal:  Angew Chem Int Ed Engl       Date:  2020-03-11       Impact factor: 15.336

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.